These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3318220)

  • 1. [Liver diseases in patients with kidney transplants--problems and research tasks].
    Reinke P
    Z Urol Nephrol; 1987 Sep; 80(9):551-6. PubMed ID: 3318220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
    Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
    Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autopsy analysis of the cause of death in patients with kidney transplants].
    Reinke P; David H; Scholz D; Ditscherlein G
    Z Urol Nephrol; 1988 Jan; 81(1):43-9. PubMed ID: 3284241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
    Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.
    Segovia R; Sánchez-Fueyo A; Rimola A; Grande L; Bruguera M; Costa J; Soguero C; Uriz J
    Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of diseases following orthotopic liver transplantation.
    Kotlyar DS; Campbell MS; Reddy KR
    Am J Gastroenterol; 2006 Jun; 101(6):1370-8. PubMed ID: 16771963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population.
    Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang RH; Lau GK; Kwong YL
    Transplantation; 2003 Jul; 76(1):169-76. PubMed ID: 12865805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic liver and kidney disease: post-transplant kidney function in patients receiving pre-emptive kidney transplantation.
    Martin AP; Bartels M; Kiehle A; Hauss J; Fangmann J
    Transpl Int; 2008 Mar; 21(3):263-7. PubMed ID: 18167152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serological markers of hepatitis B virus after renal transplantation.
    Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
    Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
    Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study.
    De Feo TM; Poli F; Mozzi F; Moretti MP; Scalamogna M;
    Transplant Proc; 2005 Mar; 37(2):1238-9. PubMed ID: 15848681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset post-transplantation food allergy in children--is it attributable only to the immunosuppressive protocol?
    Levy Y; Davidovits M; Cleper R; Shapiro R
    Pediatr Transplant; 2009 Feb; 13(1):63-9. PubMed ID: 18179638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.